Literature DB >> 19556270

Meperidine-induced serotonin syndrome in a susceptible patient.

S-L Guo1, T-J Wu, C-C Liu, C-C Ng, C-C Chien, H-L Sun.   

Abstract

We present a patient with a history of clomipramine-induced serotonin syndrome 5 yr prior who developed serotonin syndrome after a single dose of meperidine. This report heightens appreciation of population at risk and also recognition of potential toxicity in meperidine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556270     DOI: 10.1093/bja/aep167

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  Famotidine-induced reversal of meperidine-related serotonin syndrome: a case report.

Authors:  Soohyun Joe; Eunju Kim; Junyi Park; Dongwon Lee; Jongchul Son; Hyun Kim
Journal:  Korean J Anesthesiol       Date:  2017-01-11

2.  Declines and pronounced regional disparities in meperidine use in the United States.

Authors:  John M Boyle; Kenneth L McCall; Stephanie D Nichols; Brian J Piper
Journal:  Pharmacol Res Perspect       Date:  2021-08

3.  Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome.

Authors:  Anna Rickli; Evangelia Liakoni; Marius C Hoener; Matthias E Liechti
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.